Tom G Schwan Selected Research

Relapsing Fever

1/2020	Transgenic functional complementation with a transmission -associated protein restores spirochete infectivity by tick bite.
10/2015	Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite.
1/2013	Periplasmic flagellar export apparatus protein, FliH, is involved in post-transcriptional regulation of FlaB, motility and virulence of the relapsing fever spirochete Borrelia hermsii.
1/2012	Endemic foci of the tick-borne relapsing fever spirochete Borrelia crocidurae in Mali, West Africa, and the potential for human infection.
4/2010	A novel surface antigen of relapsing fever spirochetes can discriminate between relapsing fever and Lyme borreliosis.
12/2009	Characterization of a novel relapsing fever spirochete in the midgut, coxal fluid, and salivary glands of the bat tick Carios kelleyi.
8/2009	Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia.
12/2008	Relapsing fever spirochetes retain infectivity after prolonged in vitro cultivation.
11/2008	Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes.
8/2007	Purine salvage pathways among Borrelia species.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tom G Schwan Research Topics

Disease

17	Relapsing Fever 01/2020 - 02/2003
11	Infections 01/2019 - 02/2002
7	Lyme Disease (Disease, Lyme) 04/2010 - 02/2003
3	Persistent Infection 04/2014 - 10/2005
2	Tick Bites 01/2020 - 10/2015
1	Tick-Borne Diseases (Tick-Borne Disease) 08/2009
1	Fever (Fevers) 01/2007
1	Thrombocytopenia (Thrombopenia) 10/2003
1	Coinfection 10/2002

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
4	AntibodiesIBA 01/2012 - 12/2006
4	AntigensIBA 04/2010 - 06/2006
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 03/2004
3	Immunoglobulin M (IgM)IBA 04/2010 - 12/2006
3	glycerophosphodiester phosphodiesteraseIBA 08/2009 - 02/2003
3	DNA (Deoxyribonucleic Acid)IBA 12/2008 - 10/2005
2	1-oleoyl-2-stearoylphosphatidylcholineIBA 01/2020 - 10/2005
2	VaccinesIBA 01/2017 - 10/2015
2	Lipoproteins (Lipoprotein)IBA 12/2006 - 02/2002
2	EnzymesIBA 05/2006 - 02/2003
2	OspC proteinIBA 10/2005 - 03/2004
1	Protein Sorting Signals (Signal Peptide)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Therapeutic UsesIBA 01/2017
1	Recombinant ProteinsIBA 04/2010
1	Surface Antigens (Surface Antigen)IBA 04/2010
1	IntegrinsIBA 01/2010
1	LigandsIBA 01/2010
1	Concatenated DNAIBA 12/2009
1	Immunoglobulin G (IgG)IBA 08/2009
1	PorinsIBA 11/2008
1	OspA proteinIBA 11/2008
1	Amino Acids FDA Link 11/2008
1	HypoxanthineIBA 08/2007
1	purineIBA 08/2007
1	benzophenone-4'-heptyl-4-pentanoic acidIBA 05/2006
1	Serine Proteases (Serine Protease)IBA 05/2006
1	NicotinamidaseIBA 07/2005
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 10/2003
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2002
1	Biological ProductsIBA 02/2002